Genitourinary Syndrome of Menopause
Source : https://effectivehealthcare.ahrq.gov/products/genitourinary-syndrome/key-questions
Introduction The Patient-Centered Outcomes Research Institute (PCORI) is partnering with the Agency for Healthcare Research and Quality (AHRQ) to develop a systematic evidence review on Genitourinary Syndrome of Menopause. The American Urological Association (AUA) plans to use this systematic evidence review to develop related clinical guidelines.
Discussion: The negative effect of GSM on quality of life is substantial; as many as 85% of patients over 40 years of age report vaginal dryness, 29-59% report dyspareunia, 26-77% report vaginal itching and irritation and 40-68% report negative consequences on their sex life, including decreased sexual satisfaction and frequency.
Per ACOG even breast cancer survivors can use it.